Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Lupin Pharmacare Limited, was an unlisted public company incorporated on 10 January, 2007. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital was INR 2.00 cr and the total paid-up capital was INR 1.05 cr.
The current status of Lupin Pharmacare Limited is - Amalgamated.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Kamal Kishore Sharma | 00209430 | 17 years |
| Director | Rajesh Matasevak Dubey | 00230667 | 18 years |
| Director | Nilesh Deshbandhu Gupta | 01734642 | 17 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| TEMPLECRAFT REALTY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TEMPLERIVIERE PROPERTY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TEMPLE WELLNESS VENTURES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| SEQUENT SCIENTIFIC LIMITED |
Active
|
49.9 Cr | 1 | Maharashtra |
| TEMPLETREE PROPERTIES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| ALIVIRA ANIMAL HEALTH LIMITED |
Active
|
47.8 Cr | 1 | Maharashtra |
| VIYASH LIFE SCIENCES PRIVATE LIMITED |
Active
|
334.4 Cr | 1 | Telangana |
| FAISA FINANCIAL P LTD |
Active
|
52.0 L | 1 | Maharashtra |
| TEMPLE WELLNESS VENTURES INDIA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| SYMED LABS LIMITED |
Active
|
93.0 L | 1 | Telangana |
| SHILPA MEDICARE LIMITED |
Active
|
9.8 Cr | 1 | Karnataka |
| VARIJA LEASING AND FINANCE LIMITED |
Amalgamated
|
20.0 L | 1 | Maharashtra |
| BADHIRA LEASING AND FINANCE PRIVATE LTD |
Amalgamated
|
20.0 L | 1 | Maharashtra |
| TIMITA LEASING AND FINANCE PVT LTD |
Amalgamated
|
20.0 L | 1 | Maharashtra |
| YOGINI LEASING AND FINANCE PVT LTD |
Amalgamated
|
1.0 Cr | 1 | Maharashtra |
| PIPLESHWAR HOLDING PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| GOA VINYLS LIMITED |
Amalgamated
|
40.0 L | 1 | Maharashtra |
| ZYMA LABORATORIES LIMITED |
Amalgamated
|
1.4 Cr | 1 | Maharashtra |
| ORGO MERCANTILE TRADERS PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| D. B. ESTATE TRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| RAHAS MULTITRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| BS MERC PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| ZYMA PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| LUPIN INTERNATIONAL PRIVATE LIMITED |
Amalgamated
|
5.0 L | 1 | Maharashtra |
| RAHAS INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 1 | Maharashtra |
| NOVODIGM LIMITED |
Amalgamated
|
2.4 Cr | 1 | Gujarat |
| NOVEL CLINICAL RESEARCH (INDIA) PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
| ELEMENT119 LEASING AND FINANCE PRIVATE LIMITED |
Dissolved
|
2.0 Cr | 1 | Maharashtra |
| LUPIN PROPERTIES LIMITED |
Amalgamated
|
5.2 L | 1 | Maharashtra |
| RAHAS MERCANTILE PRIVATE LIMITED |
Amalgamated
|
108.0 Cr | 1 | Maharashtra |
| SYNCHEM PROPERTIES PRIVATE LIMITED |
Active
|
11.0 Cr | 1 | Maharashtra |
| VISIOMED INVESTMENTS PRIVATE LIMITED |
Active
|
5.0 Cr | 1 | Maharashtra |
| LUPIN BIOLOGICS LIMITED |
Active
|
15.0 L | 1 | Maharashtra |
| LUPIN ATHARV ABILITY LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| LUPIN MANUFACTURING SOLUTIONS LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| LUPIN INVESTMENTS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| POLYNOVA INDUSTRIES LIMITED |
Active
|
23.0 Cr | 1 | Maharashtra |
| LUPIN DIGITAL HEALTH LIMITED |
Active
|
62.3 Cr | 1 | Maharashtra |
| LUPIN DIAGNOSTICS LIMITED |
Active
|
202.6 Cr | 1 | Maharashtra |
| LUPIN LIMITED |
Active
|
91.2 Cr | 1 | Maharashtra |
The incorporation date of LUPIN PHARMACARE LIMITED is 10 January, 2007
The authorized share capital of LUPIN PHARMACARE LIMITED is INR ₹ 2.0 Cr.
The paid-up capital of LUPIN PHARMACARE LIMITED is INR ₹ 1.1 Cr.
The registered address of LUPIN PHARMACARE LIMITED is 159, CST Road, Kalina Santacruz (E) Mumbai Mumbai City Maharashtra - 400098
The CIN number of LUPIN PHARMACARE LIMITED is U24297MH2007PLC166891.
Expand
Delete
Collapse
See
details
